Author:
Bar-Dayan Y.,Kaveri S. V.,Bar-Dayan Y.,Pashov A.,Shoenfeld Y.,Kazatchkine M. D.
Publisher
Springer Berlin Heidelberg
Reference68 articles.
1. Abe J, Kotzin BL, Meissner C, Melish ME, Takahshi M, Fulton D, Romagne F, Me- lissen B, Leung DYM (1993) Characterization of T cell repertoire changes in acute Kawasaki disease. J Exp Med 177: 791 – 796
2. Abe Y, Horiuchi A, Miyake M, Kimura S (1994) Anti-cytokine nature of human immunoglobulin: one possible mechanism of the clinical effect of intravenous therapy. Immunol Rev 139: 5 – 19
3. Achiron A, Barak Y, Sarova-Pinhas I, Achiron R, Gabbay U, Rotstein Z, Noy S (1996) Intravenous immunoglobulin in relapsing-remitting multiple sclerosis. In: Kazatchkine MD, Morel A (eds) Intravenous immunoglobulin research and therapy. Parthenon Publishing Group Ltd., London, pp 289 – 294
4. Achiron A, Margalit R, Hershkoviz R, Markovits D, Reshef T, Melamed E, Cohen IR, Lider O (1994) Intravenous immunoglobulin treatment of experimental T cell- mediated autoimmune disease. Upregulation of T cell proliferation and downreg- ulation of tumor necrosis factor alpha secretion. J Clin Invest 93: 600 – 605
5. Amran A, Renz H, Lack G, Bradley K, Gelfand EW (1994) Suppression of cytokine- dependent human T-cell proliferation by intravenous immunoglobulin. Clin Immunol Immunopathol 73:180-186 Andersson UG, Bjork L, Skansén-Saphir U, Andersson JP (1994) Pooled human IgG modulates cytokine production in lymphocytes and monocytes. Immunol Rev 139: 21 – 42